Home

Bortezomib for multiple myeloma

NICE has published final guidance on the use of bortezomib (Velcade) for the treatment of multiple myeloma.

Sign in

In order to continue you need to be a registered user. If you would like to register to Nursing Times then click here.

Already Registered


Remember Me

New User?

If you are a new user and would like to register to Nursing Times then click here.



Register

Forgotten Password / Username

Enter your email *